跳至主要内容
临床试验/DRKS00033610
DRKS00033610尚未招募不适用

Course and outcome of pregnancies in patients with Restless Legs Syndrome (RLS) - an evaluation of the German Embryotox database - RLS

Charité-Universitätsmedizin Berlin0 个研究点目标入组 900 人开始时间: 2024年2月9日最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
入组人数
900

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
one 至 one(—)
性别
Female

入选标准

  • Enrollment of pregnancies, of which neither the outcome nor pathological results of prenatal diagnostics are known at the first contact.

排除标准

  • Therapy of maternal malignancies during pregnancy and cases with maternal exposure considered as potent teratogens or fetotoxicants: i.e. valproate, topiramate and carbamazepine as well as acenocoumarol, ACE-inhibitors and AT1-antagonists (exposure in 2nd and 3rd trimester),
  • lenalidomide, methotrexate, mycophenolate, phenobarbital,
  • phenprocoumon, phenytoin, retinoids (acitretin, adapalen, isotretinoin, tazaroten, tretinoin), thalidomide and warfarin.

研究者

相似试验

Course and outcome of pregnancies in patients with... | 临床试验